A Claxton

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression
    A J Claxton
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Br J Psychiatry 177:163-8. 2000
  2. ncbi request reprint Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder
    A Claxton
    Lilly Research Laboratories, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 61:928-32. 2000
  3. ncbi request reprint A systematic review of the associations between dose regimens and medication compliance
    A J Claxton
    Global Health Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 23:1296-310. 2001

Detail Information

Publications3

  1. ncbi request reprint Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression
    A J Claxton
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Br J Psychiatry 177:163-8. 2000
    ..Patients with depression are often not prescribed antidepressants for an adequate period of time...
  2. ncbi request reprint Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder
    A Claxton
    Lilly Research Laboratories, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 61:928-32. 2000
    ..A new formulation of enteric-coated fluoxetine given once weekly could be a useful option for the long-term treatment of depression, but compliance to once-weekly fluoxetine treatment has not been assessed...
  3. ncbi request reprint A systematic review of the associations between dose regimens and medication compliance
    A J Claxton
    Global Health Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 23:1296-310. 2001
    ..However, compliance in most of these studies was based on patient self-report, blood-level monitoring, prescription refills, or pill count data, none of which are as accurate as electronic monitoring (EM)...